Search

Work at the Max Planck Institute of Molecular Physiology has revealed a welcome surprise: a potential new class of COVID-19 drugs.

A pill developed at MIT and inspired by tortoises could replace injections for monoclonal antibody therapies.

Meet the international coalition working to tackle COVID-19 in low- and middle-income countries.

An institute for the gifted with X in its name, presided over by a wise doctor, has launched two new projects. Somebody call Magneto!

Pfizer-BioNTech COVID-19 vaccine receives full FDA approval.

Swiss firm Lonza is taking its investment in China to the next level with a manufacturing upgrade to its key site in Guangdong Province.

Inhalers still don’t work as well as they should, but computational modeling is here to help.

AI is expanding into medicine. Are the world’s regulators ready?

Salicylanilides have been a reliable treatment against tapeworms for much of pharma’s history. Now, they could be used to help fight COVID-19.

What strategies can pharma employ to protect itself against cyber threats?